Dirk Jan A. R. Moes - Concepedia

Author

Dirk Jan A. R. Moes

Also Known As

D J A Moes, D J A R Moes, D Moes, D Moës, D. J. A. R Moes, D. J. A. R. Moes, D. J.A.R. Moes, D. Moes, D. Moës, D.-J. Moes

161

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Radboud University Nijmegen Radboud University Medical Center Leiden University The Netherlands Cancer Institute

About

Dirk Jan A. R. Moes is an author at Leiden University Medical Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	326
2	Health Sciences	3	3	68
3	Engineering	1	1	15
4	Natural Sciences	1	1	11
5	Allergy Medicine	1	1	15

Dirk Jan A. R. Moes

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Prospective nationwide outcome audit of surgery for suspected acute appendicitis Charles C. van Rossem, M. D. M. Bolmers, Marc H. F. Schreinemacher, British journal of surgery	2015	104
A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients Louise M. Andrews, Dennis A. Hesselink, Ron H. N. van Schaik, British Journal of Clinical Pharmacology	2018	98
Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device Tom C. Zwart, Sumit R.M. Gokoel, Paul J. M. van der Boog, British Journal of Clinical Pharmacology	2018	96
Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study Anabel Sanchez‐Spitman, Vincent O. Dezentjé, Jesse J. Swen, Journal of Clinical Oncology	2019	88
Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients Dirk Jan A. R. Moes, Rogier R. Press, Jan den Hartigh, Clinical Pharmacokinetics UrologyTransplantationRenal FunctionKidney TransplantKidney Transplantation	2012	79
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study Stefanie L. Groenland, Ruben A.G. van Eerden, Kim Westerdijk, Annals of Oncology Precision DosingTherapeutic Drug MonitoringMedicinePharmacologyProspective Multicenter Study	2022	69
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics Soufian Meziyerh, Tom C. Zwart, Ronald W. van Etten, American Journal of Transplantation	2020	63
Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19 Klemens Budde, Teun van Gelder, Stein Bergan, Therapeutic Drug Monitoring ImmunologyPharmacotherapyAntiviral DrugCovid-19Drug Resistance	2022	55
Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients Dirk Jan A. R. Moes, Sebastiaan A. S. van der Bent, Jesse J. Swen, European Journal of Clinical Pharmacology	2015	53
Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer Djoeke de Wit, T Schneider, Dirk Jan A. R. Moes, Cancer Chemotherapy and Pharmacology	2016	51

Page 1